Overview
Tracy George is a Hematologist practicing medicine in Salt Lake City, Utah.
Dr. George is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Acute Myeloid Leukemia (AML), Hip Resurfacing, and Tissue Biopsy.
Dr. George is board certified in American Board Of Pathology. She is actively involved in clinical research, co-authoring 165 peer reviewed articles. Dr. George is currently accepting new patients.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- POS
- EPO
- HMO
- PPO
Locations
85 N Medical Dr, Salt Lake City, UT 84112
50 N Medical Dr, Salt Lake City, UT 84132
500 S Chipeta Way, Salt Lake City, UT 84108
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Narendranath Epperla is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Epperla is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Epperla is board certified in American Board Of Internal Medicine. Dr. Epperla is currently accepting new patients.
Univ. Of Utah Hosp. Im-Hematology-Hematologic
Josef Prchal is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Prchal is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), and Bone Marrow Transplant. Dr. Prchal is board certified in American Board Of Internal Medicine. Dr. Prchal is currently accepting new patients.
Huntsman Cancer Institute Bmt
Douglas Sborov is a Hematologist practicing medicine in Salt Lake City, Utah. He has been practicing medicine for over 17 years. Dr. Sborov is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Sborov is board certified in American Board Of Internal Medicine. Dr. Sborov is currently accepting new patients.
Huntsman Cancer Institute, Hematology-Oncology
Srinivas Tantravahi is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Tantravahi is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Myelofibrosis, Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Tantravahi is board certified in American Board Of Internal Medicine. Dr. Tantravahi is currently accepting new patients.
University Of Utah Hospital Services
Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah. Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium). He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy. Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant. For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia. This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion. His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure. Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process. To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Aplastic Anemia, and Bone Marrow Transplant. Dr. Pulsipher is board certified in American Board Of Pediatrics. Dr. Pulsipher is currently accepting new patients.
Huntsman Cancer Institute Bmt
Charles Parker is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Parker is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Acute Hepatic Porphyria (AHP), Porphyria, Acute Intermittent Porphyria, Paroxysmal Nocturnal Hemoglobinuria (PNH), and Bone Marrow Aspiration. Dr. Parker is board certified in American Board Of Internal Medicine. Dr. Parker is currently accepting new patients.
Frequently Asked Questions about Dr. Tracy I. George
How do I make an appointment with Dr. Tracy I. George?
You can book an appointment with Dr. Tracy I. George by calling their office at 801-581-2507. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Tracy I. George a top-rated expert for Systemic Mastocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tracy I. George is classified as an Elite expert for Systemic Mastocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Tracy I. George specialize in?
While Dr. Tracy I. George is a Hematology, they have specific expertise in Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Tracy I. George participate in research or clinical trials?
Yes. Dr. Tracy I. George has published 165 articles and abstracts on conditions like Systemic Mastocytosis. You can view a list of Dr. Tracy I. George's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Tracy I. George accept my insurance?
Dr. Tracy I. George accepts most major insurance plans, including AvMed and Cigna. We recommend calling the office directly at 801-581-2507 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mast Cell Activation Syndrome (MCAS)
- Systemic MastocytosisDr. George isElite. Learn about Systemic Mastocytosis.
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. George isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Hypereosinophilic SyndromeDr. George isDistinguished. Learn about Hypereosinophilic Syndrome.
- LeukemiaDr. George isDistinguished. Learn about Leukemia.
- Advanced
- AnemiaDr. George isAdvanced. Learn about Anemia.
- Chronic Myelomonocytic Leukemia (CMML)
- Essential ThrombocythemiaDr. George isAdvanced. Learn about Essential Thrombocythemia.
- Hip ResurfacingDr. George isAdvanced. Learn about Hip Resurfacing.
- Myelodysplastic Syndrome (MDS)Dr. George isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Myeloproliferative Neoplasms (MPN)
- Philadelphia-Negative Chronic Myeloid Leukemia
- Sideroblastic AnemiaDr. George isAdvanced. Learn about Sideroblastic Anemia.
- Experienced
- Acute Erythroid Leukemia (AEL)Dr. George isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Lymphoblastic Leukemia (ALL)Dr. George isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- B-Cell LymphomaDr. George isExperienced. Learn about B-Cell Lymphoma.
- Blood ClotsDr. George isExperienced. Learn about Blood Clots.
- Castleman DiseaseDr. George isExperienced. Learn about Castleman Disease.
- Chronic B-Cell Leukemia (CBCL)Dr. George isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. George isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. George isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- DRESS SyndromeDr. George isExperienced. Learn about DRESS Syndrome.
- EndoscopyDr. George isExperienced. Learn about Endoscopy.
- HemolysisDr. George isExperienced. Learn about Hemolysis.
- Hemophagocytic LymphohistiocytosisDr. George isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- Hereditary Alpha-TryptasemiaDr. George isExperienced. Learn about Hereditary Alpha-Tryptasemia.
- HistiocytosisDr. George isExperienced. Learn about Histiocytosis.
- LeukocytosisDr. George isExperienced. Learn about Leukocytosis.
- Multiple MyelomaDr. George isExperienced. Learn about Multiple Myeloma.
- MyelofibrosisDr. George isExperienced. Learn about Myelofibrosis.
- Non-Hodgkin LymphomaDr. George isExperienced. Learn about Non-Hodgkin Lymphoma.
- Non-Langerhans-Cell HistiocytosisDr. George isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- POEMS SyndromeDr. George isExperienced. Learn about POEMS Syndrome.
- ReticulohistiocytomaDr. George isExperienced. Learn about Reticulohistiocytoma.
- Richter SyndromeDr. George isExperienced. Learn about Richter Syndrome.
- Rosai-Dorfman DiseaseDr. George isExperienced. Learn about Rosai-Dorfman Disease.
- RUNX1 Familial Platelet DisorderDr. George isExperienced. Learn about RUNX1 Familial Platelet Disorder.
- Smoldering Multiple MyelomaDr. George isExperienced. Learn about Smoldering Multiple Myeloma.
- SplenomegalyDr. George isExperienced. Learn about Splenomegaly.
- ThrombocytopeniaDr. George isExperienced. Learn about Thrombocytopenia.
- Tissue BiopsyDr. George isExperienced. Learn about Tissue Biopsy.
